IRIS
Demichelis, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.151
AS - Asia 4.617
EU - Europa 3.965
SA - Sud America 881
Continente sconosciuto - Info sul continente non disponibili 384
AF - Africa 118
OC - Oceania 38
Totale 27.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.782
SG - Singapore 1.908
IT - Italia 892
CN - Cina 854
VN - Vietnam 737
BR - Brasile 702
RU - Federazione Russa 552
FI - Finlandia 424
DE - Germania 366
SE - Svezia 352
GB - Regno Unito 338
HK - Hong Kong 278
UA - Ucraina 272
CA - Canada 229
FR - Francia 221
LV - Lettonia 160
KR - Corea 145
IN - India 140
BD - Bangladesh 93
ID - Indonesia 73
NL - Olanda 61
ES - Italia 60
AR - Argentina 59
BG - Bulgaria 58
IQ - Iraq 54
JP - Giappone 49
ZA - Sudafrica 47
TR - Turchia 46
MX - Messico 44
PL - Polonia 43
AT - Austria 42
JO - Giordania 38
AU - Australia 33
PK - Pakistan 32
CO - Colombia 30
VE - Venezuela 27
EC - Ecuador 22
LU - Lussemburgo 22
PH - Filippine 21
IL - Israele 19
JM - Giamaica 18
LT - Lituania 16
MA - Marocco 16
CR - Costa Rica 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
IE - Irlanda 13
CZ - Repubblica Ceca 12
NP - Nepal 12
PY - Paraguay 11
SA - Arabia Saudita 11
BE - Belgio 10
GT - Guatemala 10
KE - Kenya 10
NI - Nicaragua 10
TH - Thailandia 9
TN - Tunisia 9
UY - Uruguay 9
CH - Svizzera 8
LB - Libano 8
RO - Romania 8
EG - Egitto 7
HN - Honduras 7
MY - Malesia 7
NO - Norvegia 6
PE - Perù 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
AM - Armenia 5
AZ - Azerbaigian 5
DZ - Algeria 5
EE - Estonia 5
ET - Etiopia 5
IR - Iran 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
OM - Oman 4
PA - Panama 4
SC - Seychelles 4
CI - Costa d'Avorio 3
EU - Europa 3
GR - Grecia 3
PR - Porto Rico 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 26.736
Salva come PNG Salva come JPEG
Città #
Ashburn 1.808
Fairfield 1.720
Singapore 1.154
Chandler 956
San Jose 890
Woodbridge 793
Seattle 708
Houston 644
Jacksonville 614
Cambridge 589
Wilmington 569
Dallas 473
Santa Clara 425
Council Bluffs 423
Columbus 422
Los Angeles 389
San Mateo 334
Ann Arbor 330
Helsinki 270
Hong Kong 249
Moscow 246
Trento 232
Princeton 228
New York 212
Beijing 201
The Dalles 195
Ho Chi Minh City 190
Hanoi 176
Riga 160
Munich 156
Phoenix 147
Lauterbourg 142
Seoul 134
Boardman 121
San Diego 121
London 104
Chicago 87
Milan 80
Dearborn 79
Buffalo 74
Lawrence 71
Orem 70
São Paulo 70
San Francisco 62
Jakarta 60
Sofia 58
Como 56
Dong Ket 50
Montreal 45
Da Nang 44
Rome 44
Brooklyn 43
Nuremberg 43
Frankfurt am Main 42
Toronto 42
Falls Church 40
Redondo Beach 39
Chennai 38
Washington 37
Tokyo 36
Bremen 34
Denver 34
Hefei 34
Atlanta 33
Salt Lake City 33
Warsaw 33
Boston 31
Johannesburg 30
North Bergen 27
Norwalk 27
San Paolo di Civitate 27
Brasília 25
Haiphong 23
Shanghai 23
Tolentino 23
Des Moines 22
Guangzhou 22
Hesperange 22
Altamura 21
Belo Horizonte 21
Dublin 21
Turku 21
Baghdad 20
Bend 20
Elk Grove Village 20
Mumbai 20
Rio de Janeiro 20
Vancouver 20
Manchester 19
Melbourne 19
Curitiba 18
Miami 18
Philadelphia 17
St Louis 17
Vienna 17
Barcelona 16
Changsha 16
Izmir 16
Kilburn 16
Düsseldorf 15
Totale 18.746
Salva come PNG Salva come JPEG
Nome #
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 391
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 388
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 363
A highly specific SpCas9 variant is identified by in vivo screening in yeast 361
Inherited determinants of early recurrent somatic mutations in prostate cancer 352
Genomic correlates of clinical outcome in advanced prostate cancer 314
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 293
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 286
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays. 269
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 266
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 263
Personalized in vitro and in vivo cancer models to guide precision medicine 260
ASEQ: Fast allele-specific studies from next-generation sequencing data 256
Patient derived organoids to model rare prostate cancer phenotypes 254
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes. 241
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 240
EthSEQ: ethnicity annotation from whole exome sequencing data 238
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer 234
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. 234
The long tail of oncogenic drivers in prostate cancer 228
Clonal evolution of chemotherapy-resistant urothelial carcinoma 227
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 226
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. 221
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 221
Ancestry-specific predisposing germline variants in cancer 220
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA 216
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 211
An automated procedure to properly handle digital images in large scale tissue microarray experiments. 199
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 194
The Molecular Taxonomy of Primary Prostate Cancer 193
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 193
TPES: Tumor Purity Estimation from SNVs 190
The landscape of somatic copy-number alteration across human cancers. 189
A computational framework discovers new copy number variants with functional importance. 189
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 187
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. 185
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. 183
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model 181
In-silico identification and functional validation of allele-dependent AR enhancers 181
Charting differentially methylated regions in cancer with Rocker-meth 181
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients 178
Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations 177
A step toward functionally characterized prostate cancer molecular subtypes. 176
Antibody-based detection of ERG rearrangement-positive prostate cancer. 175
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 175
Analytical protocol to identify local ancestry-associated molecular features in cancer 170
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. 168
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay 168
Testing mutual exclusivity of ETS rearranged prostate cancer. 167
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 167
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets 166
EML4-ALK fusion lung cancer: a rare acquired event. 165
Tumor purity quantification by clonal DNA methylation signatures 165
A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. 162
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. 160
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. 159
The genomic complexity of primary human prostate cancer. 159
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. 159
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation 157
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. 157
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. 157
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer 157
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease 156
Variants at IRX4 as prostate cancer expression quantitative trait loci. 155
Digital Pathology: Science Fiction? 155
Role of non-coding sequence variants in cancer 155
Large oncosomes mediate intercellular transfer of functional microRNA. 154
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer 154
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. 153
Plasma AR and abiraterone-resistant prostate cancer 153
Punctuated evolution of prostate cancer genomes. 152
Oncogene-mediated alterations in chromatin conformation 152
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment 152
Better screened than sorry!-an informed panel of inherited DNA repair gene variants for prostate cancer screening and prognostication 152
Integrating extracellular vesicle and circulating cell-free DNA analysis on a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients 151
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. 151
Digital storage of glass slides for quality assurance in histopathology and cytopathology. 151
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. 151
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer 151
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models 151
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. 150
The virtual case: a new method to completely digitize cytological and histological slides. 150
TMABoost: an integrated system for comprehensive management of tissue microarray data. 149
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. 149
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. 149
Mutation–selection balance and compensatory mechanisms in tumour evolution 149
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies 149
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. 148
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. 148
Circulating RNAs in prostate cancer patients 148
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression 147
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. 146
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. 146
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 145
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. 145
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. 145
Integrative clinical genomics of advanced prostate cancer 145
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 145
Tumor clone dynamics in lethal prostate cancer 144
Robotic telepathology for intraoperative remote diagnosis using a still-imaging-based system. 143
Totale 19.051
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 874
selected - selezionate 0
volume - volumi 513
Totale 113.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.475 0 0 0 0 36 81 83 390 137 212 181 355
2022/20232.024 267 235 13 328 210 316 30 145 252 34 122 72
2023/2024822 49 77 67 28 76 177 45 92 10 80 32 89
2024/20253.676 18 36 235 669 246 461 205 220 390 578 281 337
2025/20268.301 632 263 978 1.087 869 542 1.454 235 757 620 488 376
2026/20273.096 281 479 975 1.320 41 0 0 0 0 0 0 0
Totale 27.154